Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020

By afschroeder • March 7, 2026

Donohue J, Wang B, Tang L, Kim JY, Junker S, Cole E, Chang CH, Roberts E, Wilson JD, Essien U, Gifford K, Hammerslag L, Talbert J, Ahrens K, Idala D, Mohamoud S, Clark S, Austin A, Ware O, Tossone K, Mack A, Fry C, Gordon AJ, Barnes A, Marks S, Cunningham P, Allen L, Burns M, Kennedy S. Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020. J Subst Use Addict Treat. 2026 Mar 4:209924. doi: 10.1016/j.josat.2026.209924. Epub ahead of print. PMID: 41791553.

Tags: buprenorphine, General Internal Medicine, medicaid, Medication for opioid-use disorder, methadone, naltrexone, Overdose, Publications, Racial/ethnic differences, Veterans Administration

Communicating Precision Medicine Research: Multidisciplinary Teams and Diverse Communities

Beans JA, Trinidad SB, Blacksher E, Hiratsuka VY, Spicer P, Woodahl EL, Boyer BB, Lewis CM Jr, Gaffney PM, Garrison NA, Burke W. Communicating Precision[...]

A Spanish-language educational intervention to enhance diabetes outcomes among existing continuous glucose monitor users in a federally qualified health care center

Tavares M, Khoshbin K, Solorzano W, Scarlett L, Santana C, Lopez R, Villanueva GP, Escobar B, Mangual KS, Pavlish C, Bush NJ, Moin T, Everett[...]

Lung Cancer Screening Centralization Is Associated With Improved Screening Uptake: The Veterans Healthcare Administration’s Experience 2015-2021

Benjamin LN, Núñez ER, Chen L, Motwani Y, Yuan A, Vangala S, Slatore CG, Wiener RS, Elashoff DA, Yano EM, Washington DL, Mangione CM. Lung[...]